Sarah Lopas# QUERY93bf184ea67c66d3327d5fddecb4f8c7
Sarah Lopas# QUERYa6e222de17bd13570b3f85f2655dd9dc
Sarah Lopas# QUERY4f8021063ab37063f4beba750cc5d5c7
Sarah Lopas# QUERY336b0940fb0581c0a437a554a0dd02b3
Sarah Lopas OR Sarah Lopas
Sarah Lopas# QUERY009ccb169a10e917eb0ed068e051476d
Sarah Lopas# QUERY0655ee861779dfe618c0b62cf12f34d8
Sarah Lopas# QUERY5201fbc364b8217c6ae87d9fb84197d5
Sarah Lopas
Sarah Lopas# QUERY50826f2238039bac88da673651f17df6
Sarah Lopas# QUERYa95a7ce602337a1b4ea5a1c844fcef45
NRC/NMSS/MSST/SLPB false
Sarah Lopas# QUERY992b67b3faccbfa43d9642659335d7ce
NRC/NMSS/MSST/SLPB true
Sarah Lopas# QUERY4c96255679d947c48d0f134aa3f0b723
NRC Headquarters
Sarah Lopas# QUERYde076fd0735aa8b856faf204727da28d
Press Release-11-220, NRC Seeks Public Input on the Draft Environmental Impact Statement for Lee Nuclear Station New Reactors; Meetings Scheduled Jan. 19
Press Release-10-094, NRC Seeking Additional Environmental Scoping Comments Regarding Lee New Reactor Application, Meeting June 17
Press Release-I-08-026, NRC Seeks Public Input on Environmental Impact Statement for Three Mile Island 1 License Renewal Application
NRC-2009-0267, Notice of Availability of the Final Supplement 37 to the Generic Environmental Impact Statement for License Renewal of Nuclear Plants, Regarding the License Renewal of Three Mile Island Nuclear Station, Unit 1
STC-19-023, State and Tribal Communication Letter -FRN & Public Meetings Regarding Draft Application for Training and Experience Requirements for Radiopharmaceutical
PMNS20200417, Public Seminar to Discuss Temporary Regulatory Relief Pathways for NRC Medical Licensees During the COVID-19 Public Health Emergency
STC-20-055, Letter Issuance of MD 5.1, Consultation and Coordination with Governments and Indian Tribes
PMNS20200780, Closed Government-to-Government Meeting with Agreement States to Discuss Radiopharmaceutical Extravasation and Medical Event Reporting
PMNS20201009, U.S. Food and Drug Administration (Fda) and U.S. Nuclear Regulatory Commission (NRC) Workshopenhancing Development of Emerging Technologies: Radiopharmaceuticals and Radiological Devices
PMNS20201295, U.S. Nuclear Regulatory Commission Webex Meeting to Discuss COVID-19 Regulatory Relief for Medical and Other Materials Licensees
STC-20-076, Notification of Upcoming Public Meeting to Discuss Regulatory Relief for U.S. Nuclear Regulatory Commission Medical and Other Materials Licensees Related to the Ongoing COVID-19 Public Health Emergency
PMNS20201329, U.S. Nuclear Regulatory Commission Public Comment Meeting on Radiopharmaceutical Extravasations
STC-20-079, Notification of December 8, 2020, Public Meeting to Discuss Radiopharmaceutical Extravasations
PMNS20211483, Webinar Meeting of the Advisory Committee on the Medical Uses of Isotopes
PMNS20231325, Notice of Public Meeting - Integrated Low-Level Radioactive Waste Disposal Rulemaking
RIN 3150-AL18, HI-STORM 100 Coc 1014 Amd 18 Direct Final Rule - Confirmation of Effective Date
PMNS20241407, Advance Act Section 206: NRC Licensing at Brownfield Sites - Information Exchange
PMNS20241542, Advance Act Section 206 Regulatory Issues for Nuclear Facilities at Brownfield Sites - Site Remediation, NRC Financial Requirements, Socioeconomic and Community Considerations, and NRC Population-Related Siting Requirements
STC-19-029, State and Tribal Communications Letter-Federal Register Notice Extending the Public Comment Period on Draft Approaches Regarding Training and Experience Requirements for Radiopharmaceuticals
PMNS20181168, Public Meeting (Webinar) to Accept Comments on the NRCs Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 Fr 54380)
PMNS20181167, Public Meeting to Accept Comments on the NRCs Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 Fr 54380)
PMNS20190471, Public Meeting and Webinar on the NRC Staffs Evaluation of Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive - Draft Approaches for Comment
PMNS20181146, Public Meeting (Webinar) to Accept Comments on the NRCs Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 Fr 54380)
PMNS20181166, Public Meeting to Accept Comments on the NRCs Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 Fr 54380)
STC-18-065, U.S. Nuclear Regulatory Commission Federal Register Notice and Public Meetings Regarding Training and Experience Requirements for Different Categories of Radiopharmaceuticals
DT-20-07, Management Directive 5.1, Consultation and Coordination with Governments and Indian Tribes
PMNS20190478, Webinar on the NRC Staffs Evaluation of Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive - Draft Approaches for Comment
PMNS20250247, Proposed Use of Offsite Meteorological Data for Safety Reviews and Atmospheric Dispersion Modeling, Advancenrc